BioTech TNON

Tenon Medical Implements 1-for-35 Reverse Stock Split; Today

(RTTNews) - Tenon Medical, Inc. (TNON) announced on Thursday, August 6, 2026, that it will implement a 1-for-35 reverse stock split today effective at 12:01, Eastern Time, on August 10, 2026. The company confirmed that its shares will begin trading on a split-adjusted basis under the existing ticker symbol "TNON," with a new CUSIP number assigned.

The reverse split, approved by shareholders at the annual meeting on July 23, is intended to raise the per-share trading price to meet Nasdaq's minimum $1.00 average closing price requirement for continued listing on the Nasdaq Capital Market. No fractional shares will be issued, with positions rounded up to the nearest whole share. Vstock Transfer, LLC will serve as the exchange agent.

Tenon Medical, headquartered in Los Gatos, California, develops and markets sacroiliac joint fusion systems, including the Catamaran SI Joint Fusion System and SImmetry+ SI Joint Fusion System. The reverse split does not alter the company's fundamentals but is a mechanical adjustment to maintain compliance with Nasdaq listing requirements.

TNON has traded between $0.12 and $60.90 over the past year. The stock closed Friday's trading (August 7, 2026) at $0.13, down 22.02%. During afterhours trading the stock is at $0.14, up 11.15%.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Stocks Mentioned

Latest Articles

Data is currently not available